Abstract
We review the contributions and limitations of genome-wide array-based identification of copy number variants (CNVs) in the clinical diagnostic evaluation of patients with mental retardation (MR) and other brain-related disorders. In unselected MR referrals a causative genomic gain or loss is detected in 14–18% of cases. Usually, such CNVs arise de novo, are not found in healthy subjects, and have a major impact on the phenotype by altering the dosage of multiple genes. This high diagnostic yield justifies array-based segmental aneuploidy screening as the initial genetic test in these patients. This also pertains to patients with autism (expected yield about 5–10% in nonsyndromic and 10–20% in syndromic patients) and schizophrenia (at least 5% yield). CNV studies in idiopathic generalized epilepsy, attention-deficit hyperactivity disorder, major depressive disorder and Tourette syndrome indicate that patients have, on average, a larger CNV burden as compared to controls. Collectively, the CNV studies suggest that a wide spectrum of disease-susceptibility variants exists, most of which are rare (<0.1%) and of variable and usually small effect. Notwithstanding, a rare CNV can have a major impact on the phenotype. Exome sequencing in MR and autism patients revealed de novo mutations in protein coding genes in 60 and 20% of cases, respectively. Therefore, it is likely that arrays will be supplanted by next-generation sequencing methods as the initial and perhaps ultimate diagnostic tool in patients with brain-related disorders, revealing both CNVs and mutations in a single test.
References
1.
Abrahams BS, Geschwind DH: Advances in autism genetics: on the threshold of a new biology. Nat Rev Genet 9:341–355 (2008).
2.
Abrahams BS, Geschwind DH: Connecting genes to brain in the autism spectrum disorders. Arch Neurol 67:395–399 (2010).
3.
Ahn JW, Mann K, Walsh S, Shehab M, Hoang S, et al: Validation and implementation of array comparative hybridisation as a first line test in place of postnatal karyotyping for genome imbalance. Mol Cytogenet 3:9 (2010).
4.
Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F: Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 41:1061–1067 (2009).
5.
Alkan C, Coe BP, Eichler EE: Genome structural variation discovery and genotyping. Nat Rev Genet 12:363–375 (2011).
6.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th ed. (American Psychiatric Association, Washington DC 2000).
7.
Aradhya S, Manning MA, Splendore A, Cherry AM: Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features. Am J Med Genet Part A 143A:1431–1441 (2007).
8.
Aston E, Whitby H, Maxwell T, Hair N, Cowley B, et al: Comparison of targeted and whole genome analysis of postnatal specimens using a commercially available aCGH microarray platform. J Med Genet 45:268–274 (2008).
9.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56:12–28 (2007).
10.
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25:63–77 (1995).
11.
Ballif BC, Rorem EA, Sundin K, Lincicum N, Gaskin S, et al: Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet Part A 140A:2757–2767 (2006).
12.
Barber JC: Directly transmitted unbalanced chromosome abnormalities and euchromatic variants. J Med Genet 42:609–629 (2005).
13.
Baris HN, Tan W-H, Kimonis VE, Irons MB: Diagnostic utility of array-based comparative genomic hybridization in a clinical setting. Am J Med genet Part A 143A:2523–2533 (2007).
14.
Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EWC: Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 61:1135–1140 (2007).
15.
Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW: Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 17:4045–4053 (2008).
16.
Bassett AS, Scherer SW, Brzustowicz LM: Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899–914 (2010).
17.
Bernardini L, Alesi V, Loddo S, Novelli A, Bottillo I, et al: High-resolution SNP arrays in mental retardation: how much do we gain? Eur J Hum Genet 18:178–185 (2009).
18.
Betancur C: Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42–77 (2011).
19.
Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, et al: Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet 52:77–87 (2009).
20.
Bill BR, Geschwind DH: Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 19:1–8 (2009).
21.
Bradshaw NJ, Porteous DJ: DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology (2011).
22.
Bremer A, Giacobini M, Eriksson M, Gustavsson P, Nordin V, et al: Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. Am J Med Genet Part B 156:115–124 (2010).
23.
Bruining H, de Sonneville L, Swaab H, de Jonge M, Kas M, et al: Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. PLoS ONE 5:e10887 (2010).
24.
Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, et al: Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40:1466–1471 (2008).
25.
Bruno DL, Ganesamoorthy D, Schoumans J, Bankier A, Coman D, et al: Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice. J Med Genet 46:123–131 (2009).
26.
Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, et al: Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genetics 5:e1000536 (2009).
27.
Buizer-Voskamp JE, Muntjewerff J-W, Genetic Risk and Outcome in Psychosis (GROUP) Consortium, Strengman E, Sabatti C, et al: Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. Biol Psychiatry (2011a).
28.
Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, et al: Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophr Res 129:128–132 (2011b).
29.
Buysse K, Delle Chaie B, Van Coster R, Loeys B, De Paepe A, et al: Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet 52:398–403 (2009).
30.
Campbell PJ, Stephens PJ, Pleasance ED, O’Meara S, Li H, et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722–729 (2008).
31.
Carroll LS, Owen MJ: Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 1:102 (2009).
32.
Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children. JAMA 285:3093–3099 (2001).
33.
Chen W, Kalscheuer V, Tzschach A, Menzel C, Ullmann R, et al: Mapping translocation breakpoints by next-generation sequencing. Genome Res 18:1143–1149 (2008).
34.
Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, et al: Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63:1111–1117 (2008).
35.
Church DM, Lappalainen I, Sneddon TP, Hinton J, Maguire M, et al: Public data archives for genomic structural variation. Nat Genet 42:813–814 (2010).
36.
Coe BP, Ylstra B, Carvalho B, Meijer GA, MacAuley C, Lam WL: Resolving the resolution of array-CGH. Genomics 89:647–653 (2007).
37.
Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O et al: Origins and functional impact of copy number variation in the human genome. Nature 464:704–712 (2010).
38.
Cook EH, Scherer SW: Copy-number variations associated with neuropsychiatric disorders. Nature 45:919–923 (2008).
39.
Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, et al: A copy number variation morbidity map of developmental delay. Nat Genet 43:838–846 (2011).
40.
Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, et al: L1 retrotransposition in human neuronal progenitor cells. Nature 460:1127–1131 (2009).
41.
Craddock N, Sklar P: Genetics of bipolar disorder: successful start to a long journey. Trends Genet 25:99–105 (2009).
42.
Craddock N, O’Donovan MC, Owen MJ: The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42:193–204 (2005).
43.
Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, et al: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464:713–720 (2010).
44.
Cuscó I, Medrano A, Gener B, Vilardell M, Gallastegui F, et al: Autism-specific copy number variants further implicate the phosphatidylinositol signalling pathway and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genet 18:1795–1804 (2009).
45.
Dawson AJ, Riordan D, Tomiuk M, Konkin D, Anderson T, et al: Cytogenetic microarrays in Manitoba in patients with developmental delay. Clin Genet 75:498–500 (2009).
46.
de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, et al: Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 133:23–32 (2010).
47.
de Vries BB, White SM, Knight SJ, Regan R, Homfray T, et al: Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet 38:145–150 (2001).
48.
de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, et al: Diagnostic genome profiling in mental retardation. Am J Hum Genet77:606–616 (2005).
49.
Dibbens LM, Mullen S, Helbig I, Mefford HC, Bayly MA, et al: Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet 18:3626–3631 (2009).
50.
Elia J, Gai X, Xie HM, Perin JC, Geiger E, et al: Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15:637–646 (2010).
51.
Engels H, Brockschmidt A, Hoischen A, Landwehr C, Bosse K, et al: DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology 68:743–750 (2007).
52.
Esumi S, Kakazu N, Taguchi Y, Hirayama T, Sasaki A, et al: Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene clusters in single neurons. Nat Genet 37:171–176 (2005).
53.
Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, et al: Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridisation. Hum Mutat 28:1124–1132 (2007).
54.
Firth HV, Richards SM, Bevan PA, Clayton S, Corpas M: DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 84:524–533 (2009).
55.
Folstein SE, Rosen-Sheidley B: Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2:943–955 (2001).
56.
Freitag CM: The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12:2–22 (2007).
57.
Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R: Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 19:169–178 (2010).
58.
Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13:261–266 (2008).
59.
Friedman JM, Baross A, Delaney AD, Ally A, Arbour L, et al: Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 79:500–513 (2006).
60.
Friedman JM, Adam S, Arbour L, Armstrong L, Baross A, et al: Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. BMC Genomics 10:526 (2009).
61.
Gijsbers AC, Lew JY, Bosch CA, Schuurs-Hoeijmakers JH, van Haeringen A, et al: A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities. Eur J Hum Genet 17:1394–1402 (2009).
62.
Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D: Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70:898–907 (2011).
63.
Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19:R176–R187 (2010).
64.
Glessner JT, Wang K, Cai G, Korvatska O, Kim C, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569–573 (2009).
65.
Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, et al: Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 107:10584–10589 (2010a).
66.
Glessner JT, Wang K, Sleimann PM, Zhang H, Kim CE, et al: Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. PLoS ONE 5:e15463 (2010b).
67.
Goodship J, Cross I, Liling J, Wren C: A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79:348–351 (1998).
68.
Gothelf D, Schaer M, Eliez S: Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev 14:59–68 (2008).
69.
Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, et al: Rare copy number variants. A point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67:318–327 (2010).
70.
Guilmatre A, Dubourg C, Mosca A-L, Legallic S, Goldenberg A, et al: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biological pathways in schizophrenia, autism and mental retardation. Arch Gen Psychiatry 66:947–956 (2009).
71.
Hannes FD, Sharp AJ, Mefford HC, de Ravel T, Ruivenkamp CA, et al: Recurrent deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 46:223–232 (2009).
72.
Harewood L, Schütz F, Boyle S, Perry P, Delorenzi M, et al: The effect of translocation-induced nuclear reorganization on gene expression. Genome Res 20:554–564 (2010).
73.
Hayashi S, Imoto I, Aizu Y, Okamoto N, Kurosawa K, et al: Clinical application of array-based comparative genomic hybridization by two-stage screening for 536 patients with mental retardation and multiple congenital anomalies. J Hum Genet 56:110–124 (2010).
74.
Hehir-Kwa JY, Egmont-Petersen M, Janssen IM, Smeets D, Geurts van Kessel A, Veltman JA: Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis. DNA Res 14:1–11 (2007).
75.
Hehir-Kwa JY, Wieskamp N, Webber C, Pfundt R, Brunner HG, et al: Accurate distinction of pathogenic from benign CNVs in mental retardation. PLoS Comput Biol 6:e1000752 (2010).
76.
Heinzen EL, Radtke RA, Urban TJ, Cavalleri GL, Depondt C, et al: Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 86:707–718 (2010).
77.
Helbig I, Scheffer IE, Mulley JC, Berkovic SF: Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol 7:231–245 (2008).
78.
Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, et al: 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41:160–162 (2009).
79.
Henrichsen CN, Chaignat E, Reymond A: Copy number variants, diseases and gene expression. Hum Mol Genet 18:R1–R8 (2009a).
80.
Henrichsen CN, Vinckenbosch N, Zöllner S, Chaignat E, Pradervand S, et al: Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41:424–429 (2009b).
81.
Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polsta A, et al: Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet 52:161–169 (2009).
82.
Hoogendoorn ML, Vorstman JA, Jalali GR, Selten JP, Sinke RJ, et al: Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 98:84–88 (2008).
83.
Hoyer J, Dreweke A, Becker C, Göhring I, Thiel CT, et al: Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays. J Med Genet 44:629–636 (2007).
84.
Huang N, Lee I, Marcotte EM, Hurles ME: Characterizing and predicting haploinsufficiency in the human genome. PLoS Genet 6: e1001154 (2010).
85.
Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al: Detection of large-scale variation in the human genome. Nat Genet 36:949–951 (2004).
86.
Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, et al: Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 67:283–286 (2010).
87.
Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, et al: Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry 16:17–25 (2011).
88.
International Schizophrenia Consortium: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237–241 (2008).
89.
Iourov IY, Vorsanova SG, Yurov YB: Chromosomal mosaicism goes global. Mol Cytogenet 1:26 (2008).
90.
Iourov IY, Vorsanva SG, Yurov YB: Somatic genome variations in health and disease. Curr Genomics 11:387–396 (2010).
91.
Itsara A, Cooper GM, Baker C, Girirajan S, Li J, et al: Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84:148–161 (2009).
92.
Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, et al: De novo rates and selection of large copy number variation. Genome Res 20:1469–1481 (2010).
93.
Jacquemont M-L, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, et al: Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 43:843–849 (2006).
94.
Jaillard S, Drunat S, Bendavid C, Abourra A, Etcheverry A, et al: Identification of gene copy number variations in patients with mental retardation using array-CGH: novel syndromes in a large French series. Eur J Med Genet 53:66–75 (2010).
95.
Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST: American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 13:680–685 (2011).
96.
Kingsbury MA, Friedman B, McConnell MJ, Rehen SK, Yang AH, et al: Aneuploid neurons are functionally active and are integrated into brain circuitry. Proc Natl Acad Sci USA 102:6143–6147 (2005).
97.
Kirov G: The role of copy number variation in schizophrenia. Expert Rev Neurother 10:25–32 (2010).
98.
Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, et al: Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Mol Genet 18:1497–1503 (2009).
99.
Kloosterman WP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, et al: Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet 20:1916–1924 (2011).
100.
Knapp M, Romeo R, Beecham J: Economic cost of autism in the UK. Autism 13:317–336 (2009).
101.
Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, et al: Paired-end mapping reveals extensive structural variation in the human genome. Science 318:420–426 (2007).
102.
Korbel JO, Kim PM, Chen X, Urban AE, Weissman S, et al: The current excitement about copy-number variation: how it relates to gene duplications and protein families. Curr Opin Struct Biol 18:366–374 (2008).
103.
Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, et al: Whole-genome array-CGH screening of undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res 115:254–261 (2006).
104.
Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C et al: Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 17:628–638 (2008).
105.
Kurlan R: Clinical practice. Tourette’s syndrome. N Engl J Med 363:2332–2338 (2010).
106.
Le Couteur, Bailey A, Goode S, Pickles A, Robertson S, et al: A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry 37:785–801 (1996).
107.
Lesch K-P, Selch S, Renner TJ, Jacob C, Nguyen TT, et al: Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 16:491–503 (2011).
108.
Levinson DF, Duan J, Oh S, Wang K, Sanders AR, et al: Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 168:302–316 (2011).
109.
Levy D, Ronemus M, Yamrom B, Lee Y-H, Leotta A, et al: Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70:886–897 (2011).
110.
Lohoff FW: Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12:539–546 (2010).
111.
Lu X, Shaw CA, Patel A, Li J, Cooper ML, et al:Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS ONE 2:e327 (2007).
112.
Lybaek H, Meza-Zepeda LA, Kresse SH, Høysaeter T, Steen VM, Houge G: Array-CGH fine mapping of minor and cryptic HR-CGH detected genomic imbalances in 80 out of 590 patients with abnormal development. Eur J Hum Genet 16:1318–1328 (2008).
113.
MacIntyre DJ, Blackwood DH, Porteous DJ, Pickard BS, Muir WJ: Chromosomal abnormalities and mental illness. Mol Psychiatry 8:275–287 (2003).
114.
Magri C, Sacchetti E, Traversa M, Valsecchi P, Gardella R, et al: New copy number variations in schizophrenia. PLos ONE 5:e13422 (2010).
115.
Makela NL, Birch PH, Friedman JM, Marra CA: Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child’s ID. Am J Med Genet Part A 149A:2393–2402 (2009).
116.
Mangalore R, Knapp M: Cost of schizophrenia in England. J Ment Health Policy Econ 10:23–41 (2007).
117.
Männik K, Parkel S, Palta P, Zilina O, Puusepp H, et al: A parallel SNP array study of genomic aberrations associated with mental retardation in patients and general population in Estonia. Eur J Med Genet 54:136–143 (2011).
118.
Manolakos E, Vetro A, Kefalas K, Rapti S-M, Louizou E, et al: The use of array-CGH in a cohort of Greek children with developmental delay. Mol Cytogenet 3:22 (2010).
119.
Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al: Finding the missing heritability of complex diseases. Nature 461:747–753 (2010).
120.
Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477–488 (2008).
121.
McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, et al: Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41:1223–1227 (2009).
122.
McMahon JM, Scheffer IE, Nicholl JK, Waters W, Eyre H, et al: Detection of microchromosomal aberrations in refractory epilepsy: a pilot study. Epileptic Disorders 12:192–198 (2010).
123.
McMullan DJ, Bonin M, Hehir-Kwa JY, de Vries BB, Dufke A, et al: Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study. Hum Mutat 30:1082–1092 (2009).
124.
McQuillin A, Bass N, Anjorin A, Lawrence J, Kandaswamy R, et al: Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet 19:588–592 (2011).
125.
Medvedev P, Stanciu M, Brudno M: Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 6:S13–S20 (2009).
126.
Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, et al: Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 359:1685–1699 (2008).
127.
Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, et al: A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 19:1579–1585 (2009).
128.
Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, et al: Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genetics 6:e1000962 (2010).
129.
Menten B, Maas N, Thienpont B, Buysse, Vandesompele J, et al: Emerging patterns of cryptic chromosomal imbalances in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of the literature. J Med Genet 43:625–633 (2006).
130.
Miles JH: Autism spectrum disorders – a genetics review. Genet Med 13:278–294 (2011).
131.
Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, et al: Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415–1423 (2000).
132.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, et al: Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749–764 (2010).
133.
Ming JE, Geiger E, James AC, Ciprero KL, Nimmakayalu M, et al: Rapid detection of submicroscopic chromosomal rearrangements in children with multiple congenital anomalies using high density oligonucleotide arrays. Hum Mutat 27:467–473 (2006).
134.
Miyake N, Shimokawa O, Harada N, Sosonkina N, Okubo A, et al: BAC array CGH reveals genomic aberrations in idiopathic mental retardation. Am J Med Genet Part A 140A:205–211 (2006).
135.
Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, et al: Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8:685–694 (2003).
136.
Mkrtchyan H, Gross M, Hinreier S, Polytiko A, Manvelyan M, et al: Early embryonic chromosome instability results in stable mosaic pattern in human tissues. PLos One 5:e9591 (2010).
137.
Moreno-De-Luca D, SGENE Consortium, Mulle JG, Simons Simplex Collection Genetics Consortium, Kaminsky EB, et al: Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Human Genet 87:618–630 (2010).
138.
Mulle JG, Dodd AE, McGrath JA, Wolyniec PS, Mitchell AA, et al: Microdeletions of 3q29 confer high risk of autism and schizophrenia. Am J Hum Genet 87:229–236 (2010).
139.
Mulley JC, Mefford HC: Epilepsy and the new cytogenetics. Epilepsia 52:423–432 (2011).
140.
Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH: Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435:903–910 (2005).
141.
Muotri AR, Zhao C, Marchetto MC, Cage FH: Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus 19:1002–1007 (2009).
142.
Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, et al: L1 retrotransposition in neurons is modulated by MeCP2. Nature 468:443–446 (2010).
143.
Nadeau JH: Transgenerational genetic effects on phenotypic variation and disease risk. Hum Mol Genet 18:R202–R210 (2009).
144.
Nagamani SC, Erez A, Bader P, Lalani SR, Scott DA, et al: Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet 19:280–286 (2011).
145.
Need AC, Ge D, Weale ME, Maia J, Feng S, et al: A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genetics 5:e1000373 (2009).
146.
Newman WG, Hamilton S, Ayres J, Sanghera N, Smith A, et al: Array comparative genomic hybridization for diagnosis of developmental delay – an exploratory cost-consequences analysis. Clin Genet 71:254–259 (2007).
147.
Nishiyama T, Notohara M, Sumi S, Takami S, Kishino H: Major contribution of dominant inheritance to autism spectrum disorders (ASDs) in population-based families. J Hum Genet 54:721–726 (2009).
148.
Nowakowska B, Stankiewicz P, Obersztyn E, Ou Z, Chinault AC, et al: Application of metaphase HR-CGH and targeted chromosomal microarray analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features. Am J Med Genet Part A 146A:2361–2369 (2008).
149.
O’Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M et al: Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16:286–292 (2011).
150.
O’Roak BJ, Deriziotis P, Lee C, Vries L, Schwartz JJ, et al: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43:585–589 (2011).
151.
O’Rourke JA, Sharf JM, Yu D, Pauls DL: The genetics of Tourette syndrome: a review. J Psychosom Res 67:533–545 (2009).
152.
Oskarsdóttir S, Vujic M, Fasth A: Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 89:148–151 (2004).
153.
Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, et al: Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 100:289–294 (2003).
154.
Pani AM, Hobart HH, Morris CA, Mervis CA, Bray-Ward P, et al: Genome rearrangements detected by SNP microarrays in individuals with intellectual disability referred with possible Williams syndrome. PLoS ONE 5:e12349 (2010).
155.
Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, et al: Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729–7734 (2006).
156.
Pickering DL, Eudy JD, Olney AH, Dave BJ, Golden D, et al: Array-based comparative genomic hybridization analysis of 1176 consecutive clinical genetics investigations. Genet Med 10:262–266 (2008).
157.
Pietiläinen OP, Rehnstrom K, Jakkula E, Service SK, Congdon E, et al: Phenotype mining in CNV carriers from a population cohort. Hum Mol Genet 20:2686–2695 (2011).
158.
Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al: Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368–372 (2010).
159.
Piotrowski A, Bruder CE, Andersson R, de Ståhl TD, Menzel U, et al: Somatic mosaicism for copy number variation in differentiated human tissues. Hum Mutat 29:1118–1124 (2008).
160.
Poot M, Hochstenbach R: A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 12:478–485 (2010).
161.
Poot M, Badea A, Williams RW, Kas MJ: Identifying human disease genes through cross-species gene mapping of evolutionary conserved processes. PLoS ONE 6:e18612 (2011).
162.
Prasad SE, Howley S, Murphy KC: Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14:26–34 (2008).
163.
Qiao Y, Riendeau N, Koochek M, Liu X, Harvard C, et al: Phenomic determinants of genomic variation in autism spectrum disorders. J Med Genet 46:680–688 (2009).
164.
Qiao Y, Harvard C, Tyson C, Liu X, Fawcett C, et al: Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics. Hum Genet 128:179–194 (2010).
165.
Ramalingam A, Zhou X-G, Fiedler SD, Brawner SJ, Joyce JM, et al: 16p13.33 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet 56:541–544 (2011).
166.
Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, et al: Diagnostic yield of various approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet Part A 140A:2063–2074 (2006).
167.
Regier DA, Friedman JM, Marra CA: Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86:765–772 (2010).
168.
Reher SK, Yung YC, McGraig MP, Kaushal D, Yang AH, et al: Constitutional aneuploidy in the normal human brain. J Neurosci 25:2176–2180 (2005).
169.
Rietkerk T, Boks MP, Sommer IE, de Jong S, Kahn RS, Ophoff RA: Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry 14:353–355 (2009).
170.
Ritvo ER, Jorde LB, Mason-Brothers A, Freeman BJ, Pingree C, et al: The UCLA-University of Utah epidemiology survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146:1032–1036 (1989).
171.
Rodríguez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, et al: Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet 87:129–138 (2010a).
172.
Rodríguez-Santiago B, Brunet A, Sobrino B, Serra-Juhé C, Flores R et al: Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia. Mol Psychiatry 15:1023–1033 (2010b).
173.
Rooms L, Vandeweyer G, Reyniers E, van Mol K, de Cranck I, et al: Array-based MLPA to detect recurrent copy number variations in patients with idiopathic mental retardation. Am J Med Genet Part A 155A:343–348 (2011).
174.
Ropers HH: Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet 11:161–187 (2010).
175.
Rosenberg C, Knijnenburg J, Bakker E, Vianna-Morgante AM, Sloos W, et al: Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet 43:180–186 (2006).
176.
Rujescu D, Ingason A, Cichon S, Pietiläinen OP, Barnes MR, et al: Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18:988–996 (2009).
177.
Saam J, Gudgeon J, Aston E, Brothman AR: How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med 10:181–186 (2008).
178.
Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H: Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med 11:139–146 (2009).
179.
Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70:863–885 (2011).
180.
Schaefer GB, Starr L, Pickering D, Skar G, DeHaai K, Sanger WG: Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J Child Neurol 25:1498–1503 (2010).
181.
Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, et al: Challenges and standards in integrating surveys of structural variation. Nat Genet 39:S7–S15 (2007).
182.
Schinzel A: Catalogue of Unbalanced Chromosomal Aberrations in Man, 2nd ed. (Walter de Gruyter, Berlin 2001).
183.
Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid B-M, Nordenskjöld M: Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet 42:699–705 (2005).
184.
Schuurs-Hoeijmakers JH, Hehir-Kwa JY, Pfundt R, van Bon BW, de Leeuw N, et al: Homozygosity mapping in outbred families with mental retardation. Eur J Hum Genet 9:597–601 (2011).
185.
Sebat J, Lakshmi B, Troge J, Alexander J, Young J et al: Large-scale copy number polymorphism in the human genome. Science 305:525–528 (2004).
186.
Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, et al: Strong association of de novo copy number mutations with autism. Science 316:445–449 (2007).
187.
Seidman JG, Seidman C: Transcription factor insufficiency: when half a loaf is not enough. J Clin Invest 109:451–455 (2002).
188.
Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, et al: Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 149:98–102 (2006).
189.
Shaffer LG, Bejjani BA, Torchia B, Kirkpatrick S, Coppinger J, Ballif BC: The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future. Am J Med Genet Part C 145C:335–345 (2007).
190.
Shaikh TH, Gai X, Perin JC, Glessner JT, Xie H, et al: High-resolution mapping and analysis of copy number variations in the human genome: A data resource for clinical and research applications. Genome Res 19:1682–1690 (2009).
191.
Sharp AJ, Hansen S, Selzer R, Cheng Z, Regan R, et al: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38:1038–1042 (2006).
192.
Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, et al: A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 40:322–328 (2008).
193.
Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, et al: Microarray based comparative genomic hybridization (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 41:241–248 (2004).
194.
Shen Y, Miller DT, Cheung SW, Lip V, Sheng X, et al: Development of a focused oligonucleotide-array comparative genomic hybridization chip for clinical diagnosis of genomic imbalance. Clin Chem 53:2051–2059 (2007).
195.
Sheng M, Hoogenraad CC: The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 76:823–847 (2007).
196.
Shevell MI, Bejjani BA, Srour M, Rorem EA, Hall N, Shaffer LG: Array comparative genomic hybridization in global developmental delay. Am J Med Genet Part B 147:1101–1108 (2008).
197.
Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al: Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757 (2009).
198.
Shi YY, He G, Zhang Z, Tang W, Zhang J, et al: A study of rare structural variants in schizophrenia patients and normal controls from Chinese Han population. Mol Psychiatry 13:911–913 (2008).
199.
Shinawi M, Schaaf CP, Bhatt SS, Xia Z, Patel A, et al: A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 41:1269–1271 (2009).
200.
Shprintzen SJ: Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 14:3–10 (2008).
201.
Siggberg L, Ala-Mello S, Jaakkola E, Kuusinen E, Schuit R, et al: Array CGH in molecular diagnosis of mental retardation – a study of 150 Finnish patients. Am J Med Genet Part A 152A:1398–1410 (2010).
202.
Simon-Sanchez J, Scholz S, Fung HC, Matarin M, Hernandez D, et al: Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 16:1–14 (2007).
203.
Singer T, McConnell MJ, Marchetto MC, Coufal NG, Gage FH: LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurol 33:345–354 (2010).
204.
Stark KL, Xu B, Bagchi A, Lai W-S, Liu H, et al: Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 40:751–760 (2008).
205.
St Clair D, Blackwood D, Muir W, Carothers A, Walker M, et al: Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336:13–16 (1990).
206.
Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, et al: Large recurrent microdeletions associated with schizophrenia. Nature 455:232–236 (2008).
207.
Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al: Common variants conferring risk of schizophrenia. Nature 460:744–747 (2009).
208.
Sundaram SK, Huq AM, Wilson BJ, Chugani HT: Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 74:1583–1590 (2010).
209.
Szatmari P: New recommendations on autism spectrum disorder. BMJ 342:d2456 (2011).
210.
Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al: Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328 (2007).
211.
Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, et al: A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 41:535–543 (2009).
212.
Tézenas Du Montcel S, Mendizabai H, Aymé S, Lévy A, Philip N: Prevalence of 22q11 microdeletion. J Med Genet 33:719 (1996).
213.
Thuresson A-C, Bondeson M-L, Edeby C, Ellis P, Langford C, et al: Whole-genome array-CGH for detection of submicroscopic imbalances in children with mental retardation. Cytogenet Genome Res 118:1–7 (2007).
214.
Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, et al: Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26:363–372 (2010).
215.
Tucker T, Montpetit A, Chai D, Chan S, Chénier S, et al: Comparison of genome-wide array genomic hybridization platforms for the detection of copy number variants in idiopathic mental retardation. BMC Medical Genomics 4:25 (2011).
216.
Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VR, et al: Fine-scale structural variation of the human genome. Nat Genet 37:727–732 (2005).
217.
Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, et al: Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet Part A 139A:173–185 (2005).
218.
Ullmann R, Turner G, Kirchhoff M, Chen W, Tonge B, et al: Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 28:674–682 (2007).
219.
Vacic V, McCarthy S, Malhotra D, Murray F, Chou H-H, et al: Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471:499–503 (2011).
220.
van Bon BW, Mefford HC, Menten B, Koolen DA, Sharp AJ, et al: Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 46:511–523 (2009).
221.
van der Zwaag B, Franke L, Poot M, Hochstenbach R, Spierenburg HA, et al: Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS ONE 4:e5324 (2009a).
222.
van der Zwaag B, Staal WG, Hochstenbach R, Poot M, Spierenburg HA, et al: A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet Part B 153B:960–966 (2009b).
223.
van Karnebeek CD, Jansweijer MC, Leenders AG, Offinga M, Hennekam RC: Diagnostic investigation in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 13:6–25 (2005).
224.
van Spronsen M, Hoogenraad CC: Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10:207–214 (2010).
225.
Vassos E, Collier DA, Holden S, Patch C, Rujescu D, et al: Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet 19:3477–3481 (2010).
226.
Veitia RA, Birchler JA: Dominance and gene dosage balance in health and disease: why levels matter! J Pathol 220:174–185 (2010).
227.
Veitia RA, Bottani S, Birchler JA: Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects. Trends Genet 24:390–397 (2008).
228.
Vermeesch JR, Balikova I, Schrander-Stumpel C, Fryns J-P, Devriendt K: The causality of de novo copy number variants is overestimated. Eur J Hum Genet (2011).
229.
Visscher PM, Goddard ME, Derks EM, Wray NR: Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. Mol Psychiatry (2011).
230.
Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, et al: Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 73:1261–1270 (2003).
231.
Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, et al: A de novo paradigm for mental retardation. Nat Genet 42:1109–1112 (2010).
232.
Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al: Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380–384 (2011).
233.
Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L: Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11:18–28 (2006).
234.
Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA et al: Association of the PIK4CA susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet 150B:430–433 (2009).
235.
Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, et al: A double hit implicated DIAPH3 as an autism risk gene. Mol Psychiatry 16:442–451 (2011).
236.
Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Genetic Risk and Outcome in Psychosis (GROUP) Consortium, et al: Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 83:504–510 (2008).
237.
Wagenstaller J, Spranger S, Lorenz-Depiereux B, Kamierczak B, Nathrath M, et al: Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet 81:768–779 (2007).
238.
Walsh T, McClellan JM, McCarthy S, Addington AM, Pierce SB, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539–543 (2008).
239.
Wang J, Valo Z, Bowers CW, Smith DD, Liu Z, Singer-Sam J: Dual DNA methylation patterns in the CNS reveal developmentally poised chromatin and monoallelic expression of critical genes. PLoS ONE 5:e13843 (2010).
240.
Wang L-S, Hranilovic D, Wang K, Lindquist IE, Yurcaba L, et al: Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia. BMC Medical Genetics 11:134 (2010).
241.
Webber C, Hehir-Kwa JY, Nguyen D-Q, de Vries BB, Veltman JA, Ponting CP: Forging links between human mental retardation-associated CNVs and mouse gene knockout models. PLoS Genetics 5:e1000532 (2009).
242.
Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, et al: Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358:667–675 (2008).
243.
Whibley AC, Plagnol V, Tarpey PS, Abidi F, Fullston T, et al: Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. Am J Hum Genet 87:173–188 (2010).
244.
Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, et al: Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376:1401–1408 (2010).
245.
Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA: DNA copy number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signalling. Hum Mol Genet 15:743–749 (2006).
246.
Wincent J, Anderlid B-M, Lagerberg M, Nordenskjöld M, Schoumans J: High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting. Clin Genet 79:147–157 (2011).
247.
Wordsworth S, Buchanan J, Regan R, Davison V, Smith K, et al: Diagnosing idiopathic disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom. Genomic Med 1:35–45 (2007).
248.
Xiang B, Li A, Valentin D, Nowak NJ, Zhao H, Li P: Analytical and clinical validity of whole-genome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay. Am J Med Genet 146A:1942–1954 (2008).
249.
Xiang B, Zhu H, Shen Y, Miller DT, Lu K, et al: Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation. J Mol Diagnostics 12:204–212 (2010).
250.
Xie C, Tammi MT: CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 10:80 (2009).
251.
Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorou M: Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40:880–885 (2008).
252.
Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, et al: Elucidating the genetic architecture of familial schizophrenia using rare copy number variants and linkage scans. Proc Natl Acad Sci USA 106:16746–16751 (2009).
253.
Yurov YB, Iourov IY, Vorsanova SG, Liehr T, Kolotil AD, et al: Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS ONE 6:e558 (2007a).
254.
Yurov YB, Vorsanova SG, Iourov IY, Demidova IA, Beresheva AK, et al: Unexplained autism is frequently associated with low-level mosaic aneuploidy. J Med Genet 44:521–525 (2007b).
255.
Yurov YB, Iourov IY, Vorsanova SG, Demidova IA, Kravetz VS, et al: The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1. Schizophr Res 98:139–147 (2007c).
256.
Zhang D, Cheng L, Qian Y, Alley-Rodriquez N, Kelsoe JR, et al: Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14:376–380 (2009).
257.
Zhang F, Gu W, Hurles ME, Lupski JR: Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 10:451–481 (2009).
258.
Zhang Z-F, Ruivenkamp C, Staaf J, Zhu H, Barbaro M, et al: Detection of submicroscopic constitutional chromosome aberrations in clinical diagnostics: a validation of the practical performance of different array platforms. Eur J Hum Genet 16:786–792 (2008).
259.
Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, et al: A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci USA 104:12831–12836 (2007).
260.
Zoghbi HY: Postnatal developmental disorders: meeting at the synapse? Science 302:826–830 (2003).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
